Cribstone Capital Management’s Edwards Lifesciences EW Stock Holding History

Cribstone Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10	Closed	-$1K	–	487
2022 Q1	$1K	Hold	10	–	–	﹤0.01%	375
2021 Q4	$1K	Hold	10	–	–	﹤0.01%	364
2021 Q3	$1K	Sell	10 -580	-98%	-$66.2K	﹤0.01%	354
2021 Q2	$61K	Buy	+590	New	+$55.6K	0.04%	148
2019 Q1	–	Sell	-204	Closed	-$10K	–	674
2018 Q4	$10K	Hold	204	–	–	0.01%	469
2018 Q3	$12K	Hold	204	–	–	0.01%	482
2018 Q2	$10K	Hold	204	–	–	﹤0.01%	515
2018 Q1	$9K	Buy	204 +69	+51%	+$3K	﹤0.01%	515
2017 Q4	$5K	Hold	135	–	–	﹤0.01%	666
2017 Q3	$5K	Hold	135	–	–	﹤0.01%	590
2017 Q2	$5K	Hold	135	–	–	﹤0.01%	589
2017 Q1	$4K	Buy	+135	New	+$4.23K	﹤0.01%	635
2016 Q3	–	Sell	-600	Closed	-$20K	–	708
2016 Q2	$20K	Buy	+600	New	+$20.5K	0.01%	420

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cribstone Capital Management's EW Position: Q2 2022 in Review

Cribstone Capital Management sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 10 shares — an estimated $1K sold.

Cribstone Capital Management first reported a position in EW in Q2 2016 and held it in 13 quarters. The position peaked at $61K in Q2 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

Cribstone Capital Management reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
Cribstone Capital Management sold 10 Edwards Lifesciences shares in Q2 2022, an estimated $1K.
Cribstone Capital Management first reported a position in Edwards Lifesciences in Q2 2016 and held it in 13 quarters.
Cribstone Capital Management's Edwards Lifesciences position peaked at $61K in Q2 2021.
1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Cribstone Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.